rs36015759
Variant names:
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1
The NM_031433.4(MFRP):c.492C>T(p.Tyr164Tyr) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.213 in 1,613,692 control chromosomes in the GnomAD database, including 37,687 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.22 ( 3717 hom., cov: 32)
Exomes 𝑓: 0.21 ( 33970 hom. )
Consequence
MFRP
NM_031433.4 synonymous
NM_031433.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 1.39
Publications
24 publications found
Genes affected
MFRP (HGNC:18121): (membrane frizzled-related protein) This gene encodes a member of the frizzled-related protein family. The encoded protein plays an important role in eye development and mutations in this gene have been associated with nanophthalmos, posterior microphthalmia, retinitis pigmentosa, foveoschisis, and optic disc drusen. The protein is encoded by a bicistronic transcript which also encodes C1q and tumor necrosis factor related protein 5 (C1QTNF5). [provided by RefSeq, Jun 2013]
C1QTNF5 (HGNC:14344): (C1q and TNF related 5) This gene encodes a member of a family of proteins that function as components of basement membranes and may play a role in cell adhesion. Mutations in this gene have been associated with late-onset retinal degeneration. The protein may be encoded by either a bicistronic transcript including sequence from the upstream membrane frizzled-related protein gene (MFRP), or by a monocistronic transcript expressed from an internal promoter. [provided by RefSeq, Jun 2013]
C1QTNF5 Gene-Disease associations (from GenCC):
- late-onset retinal degenerationInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), G2P
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.51).
BP6
Variant 11-119345569-G-A is Benign according to our data. Variant chr11-119345569-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 143157.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=1.39 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.224 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| MFRP | NM_031433.4 | c.492C>T | p.Tyr164Tyr | synonymous_variant | Exon 5 of 15 | ENST00000619721.6 | NP_113621.1 | |
| C1QTNF5 | NM_015645.5 | c.-2145C>T | 5_prime_UTR_variant | Exon 5 of 15 | NP_056460.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.218 AC: 33077AN: 151996Hom.: 3714 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
33077
AN:
151996
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.208 AC: 51693AN: 248354 AF XY: 0.207 show subpopulations
GnomAD2 exomes
AF:
AC:
51693
AN:
248354
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.213 AC: 311105AN: 1461578Hom.: 33970 Cov.: 60 AF XY: 0.211 AC XY: 153463AN XY: 727098 show subpopulations
GnomAD4 exome
AF:
AC:
311105
AN:
1461578
Hom.:
Cov.:
60
AF XY:
AC XY:
153463
AN XY:
727098
show subpopulations
African (AFR)
AF:
AC:
7808
AN:
33478
American (AMR)
AF:
AC:
5273
AN:
44716
Ashkenazi Jewish (ASJ)
AF:
AC:
6968
AN:
26134
East Asian (EAS)
AF:
AC:
7118
AN:
39700
South Asian (SAS)
AF:
AC:
13841
AN:
86256
European-Finnish (FIN)
AF:
AC:
15794
AN:
53220
Middle Eastern (MID)
AF:
AC:
736
AN:
5768
European-Non Finnish (NFE)
AF:
AC:
241302
AN:
1111916
Other (OTH)
AF:
AC:
12265
AN:
60390
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.477
Heterozygous variant carriers
0
15184
30369
45553
60738
75922
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
8264
16528
24792
33056
41320
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.218 AC: 33088AN: 152114Hom.: 3717 Cov.: 32 AF XY: 0.216 AC XY: 16084AN XY: 74372 show subpopulations
GnomAD4 genome
AF:
AC:
33088
AN:
152114
Hom.:
Cov.:
32
AF XY:
AC XY:
16084
AN XY:
74372
show subpopulations
African (AFR)
AF:
AC:
9474
AN:
41492
American (AMR)
AF:
AC:
2312
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
AC:
917
AN:
3470
East Asian (EAS)
AF:
AC:
1013
AN:
5150
South Asian (SAS)
AF:
AC:
766
AN:
4826
European-Finnish (FIN)
AF:
AC:
3037
AN:
10592
Middle Eastern (MID)
AF:
AC:
31
AN:
294
European-Non Finnish (NFE)
AF:
AC:
14941
AN:
67978
Other (OTH)
AF:
AC:
407
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.495
Heterozygous variant carriers
0
1353
2706
4060
5413
6766
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
340
680
1020
1360
1700
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
591
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:3
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
-
Department of Ophthalmology and Visual Sciences Kyoto University
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:literature only
- -
Apr 10, 2020
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not specified Benign:2
Nov 24, 2014
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Isolated microphthalmia 6 Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Retinal degeneration Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Isolated microphthalmia 5 Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.